Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spermatozoa | 46 | 2022 | 208 | 7.830 |
Why?
|
| Chromatin | 19 | 2022 | 179 | 3.450 |
Why?
|
| DNA | 31 | 2022 | 594 | 3.270 |
Why?
|
| Nuclear Matrix | 15 | 2015 | 17 | 2.600 |
Why?
|
| Cell Nucleus | 26 | 2015 | 383 | 2.350 |
Why?
|
| DNA Replication | 11 | 2015 | 153 | 2.230 |
Why?
|
| DNA Fragmentation | 8 | 2015 | 95 | 1.980 |
Why?
|
| Origin Recognition Complex | 4 | 2017 | 22 | 1.830 |
Why?
|
| Zygote | 5 | 2016 | 39 | 1.780 |
Why?
|
| Deoxyribonucleases | 5 | 2009 | 27 | 1.290 |
Why?
|
| Meiosis | 3 | 2017 | 65 | 1.060 |
Why?
|
| DNA Topoisomerases, Type II | 5 | 2011 | 10 | 1.010 |
Why?
|
| Mice | 29 | 2017 | 6490 | 0.950 |
Why?
|
| Animals | 56 | 2017 | 16695 | 0.920 |
Why?
|
| Embryo, Mammalian | 7 | 2016 | 158 | 0.850 |
Why?
|
| Oocytes | 8 | 2011 | 147 | 0.850 |
Why?
|
| Sperm Injections, Intracytoplasmic | 8 | 2013 | 67 | 0.850 |
Why?
|
| Male | 61 | 2022 | 22779 | 0.830 |
Why?
|
| Embryonic Development | 4 | 2013 | 83 | 0.820 |
Why?
|
| Staphylococcal Infections | 2 | 2014 | 65 | 0.790 |
Why?
|
| Epididymis | 5 | 2015 | 27 | 0.750 |
Why?
|
| Psychiatry | 1 | 2022 | 35 | 0.730 |
Why?
|
| DNA Damage | 5 | 2015 | 358 | 0.730 |
Why?
|
| Semen | 1 | 2022 | 55 | 0.720 |
Why?
|
| Egtazic Acid | 4 | 2009 | 14 | 0.710 |
Why?
|
| DNA-Binding Proteins | 5 | 2012 | 557 | 0.670 |
Why?
|
| Vas Deferens | 3 | 2015 | 5 | 0.660 |
Why?
|
| Mental Health Services | 1 | 2022 | 134 | 0.660 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 239 | 0.630 |
Why?
|
| Mice, Inbred DBA | 8 | 2016 | 72 | 0.610 |
Why?
|
| Chelating Agents | 2 | 2009 | 53 | 0.590 |
Why?
|
| Spermatogenesis | 3 | 2012 | 160 | 0.580 |
Why?
|
| Parthenogenesis | 2 | 2016 | 9 | 0.570 |
Why?
|
| Alu Elements | 2 | 2007 | 12 | 0.550 |
Why?
|
| Dithiothreitol | 6 | 2013 | 18 | 0.500 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2013 | 40 | 0.500 |
Why?
|
| Protein Multimerization | 1 | 2017 | 114 | 0.490 |
Why?
|
| Embryonic and Fetal Development | 3 | 2001 | 33 | 0.490 |
Why?
|
| Cycloheximide | 1 | 2016 | 30 | 0.490 |
Why?
|
| Nuclear Proteins | 3 | 2012 | 330 | 0.480 |
Why?
|
| Mitosis | 2 | 2016 | 112 | 0.480 |
Why?
|
| Chromosomes | 5 | 2002 | 44 | 0.480 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 44 | 0.460 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2014 | 15 | 0.440 |
Why?
|
| Academies and Institutes | 1 | 2014 | 39 | 0.440 |
Why?
|
| Sarcoma | 1 | 2014 | 11 | 0.440 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2014 | 1 | 0.430 |
Why?
|
| Gloves, Surgical | 1 | 2014 | 2 | 0.430 |
Why?
|
| Operating Rooms | 1 | 2014 | 5 | 0.430 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2014 | 6 | 0.430 |
Why?
|
| Staphylococcus | 1 | 2014 | 8 | 0.430 |
Why?
|
| Intraoperative Care | 1 | 2014 | 13 | 0.430 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 14 | 0.430 |
Why?
|
| Cricetinae | 11 | 2005 | 241 | 0.430 |
Why?
|
| Protamines | 6 | 2022 | 20 | 0.420 |
Why?
|
| Comet Assay | 1 | 2013 | 77 | 0.420 |
Why?
|
| Cross Infection | 1 | 2014 | 47 | 0.410 |
Why?
|
| Nucleic Acid Conformation | 8 | 2003 | 156 | 0.410 |
Why?
|
| Cell Fractionation | 1 | 2013 | 30 | 0.400 |
Why?
|
| Survivors | 1 | 2014 | 152 | 0.400 |
Why?
|
| Calcium Chloride | 2 | 2013 | 5 | 0.390 |
Why?
|
| Humans | 33 | 2022 | 42163 | 0.390 |
Why?
|
| Calcium | 3 | 2009 | 487 | 0.370 |
Why?
|
| Apoptosis | 2 | 2012 | 1541 | 0.360 |
Why?
|
| DNA, Superhelical | 1 | 2011 | 7 | 0.350 |
Why?
|
| Testis | 1 | 2012 | 203 | 0.340 |
Why?
|
| Models, Biological | 7 | 2012 | 711 | 0.340 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 158 | 0.340 |
Why?
|
| Biomedical Research | 1 | 2014 | 467 | 0.310 |
Why?
|
| Female | 17 | 2022 | 24018 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 6 | 2013 | 1804 | 0.310 |
Why?
|
| Genome | 3 | 2007 | 149 | 0.300 |
Why?
|
| Proteins | 1 | 2011 | 383 | 0.280 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 274 | 0.280 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2007 | 4 | 0.280 |
Why?
|
| Detergents | 3 | 2002 | 25 | 0.280 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2001 | 57 | 0.270 |
Why?
|
| Expressed Sequence Tags | 1 | 2007 | 27 | 0.270 |
Why?
|
| DNA Breaks | 1 | 2006 | 5 | 0.260 |
Why?
|
| Databases, Genetic | 1 | 2007 | 103 | 0.260 |
Why?
|
| Histones | 4 | 2013 | 194 | 0.250 |
Why?
|
| Biochemistry | 1 | 2006 | 12 | 0.250 |
Why?
|
| Physiology | 1 | 2006 | 17 | 0.250 |
Why?
|
| Anatomy | 1 | 2006 | 24 | 0.240 |
Why?
|
| Chromosome Mapping | 4 | 1996 | 198 | 0.240 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 309 | 0.230 |
Why?
|
| Schools, Medical | 1 | 2006 | 208 | 0.210 |
Why?
|
| Urinary Bladder | 2 | 1995 | 30 | 0.210 |
Why?
|
| Edetic Acid | 3 | 2013 | 23 | 0.200 |
Why?
|
| Mass Screening | 2 | 1998 | 531 | 0.200 |
Why?
|
| Chromosome Aberrations | 2 | 2002 | 61 | 0.200 |
Why?
|
| Transgenes | 1 | 2002 | 65 | 0.190 |
Why?
|
| Prostatic Neoplasms | 5 | 1998 | 1068 | 0.190 |
Why?
|
| Health Personnel | 2 | 2022 | 262 | 0.190 |
Why?
|
| Manganese Compounds | 2 | 2013 | 15 | 0.180 |
Why?
|
| Mentors | 1 | 2022 | 143 | 0.180 |
Why?
|
| Infertility, Male | 4 | 2007 | 46 | 0.180 |
Why?
|
| Cryptorchidism | 1 | 2000 | 3 | 0.170 |
Why?
|
| Fertilization | 2 | 2012 | 37 | 0.170 |
Why?
|
| Chlorides | 2 | 2013 | 59 | 0.170 |
Why?
|
| Tissue Distribution | 3 | 2012 | 230 | 0.170 |
Why?
|
| Octoxynol | 3 | 2006 | 19 | 0.170 |
Why?
|
| RNA, Ribosomal, 5S | 2 | 2001 | 3 | 0.170 |
Why?
|
| Genetic Code | 1 | 2000 | 7 | 0.160 |
Why?
|
| Mesocricetus | 5 | 2003 | 56 | 0.150 |
Why?
|
| Physicians | 1 | 2021 | 180 | 0.150 |
Why?
|
| Multigene Family | 2 | 1996 | 105 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 5 | 1986 | 21 | 0.140 |
Why?
|
| Keratins | 4 | 1986 | 25 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2007 | 429 | 0.140 |
Why?
|
| United States | 4 | 2022 | 5072 | 0.140 |
Why?
|
| Mice, Inbred Strains | 4 | 2002 | 116 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2009 | 462 | 0.140 |
Why?
|
| Cations, Divalent | 2 | 2008 | 25 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 1998 | 145 | 0.130 |
Why?
|
| Telomere | 2 | 1996 | 59 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 38 | 0.120 |
Why?
|
| Deoxyribonuclease I | 2 | 2007 | 28 | 0.120 |
Why?
|
| Genes | 1 | 1995 | 56 | 0.120 |
Why?
|
| RNA, Ribosomal | 1 | 1995 | 30 | 0.120 |
Why?
|
| Urethral Obstruction | 1 | 1995 | 1 | 0.120 |
Why?
|
| Elastin | 1 | 1995 | 40 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 14 | 0.110 |
Why?
|
| Hawaii | 2 | 2014 | 2004 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2014 | 89 | 0.110 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 11 | 0.110 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2013 | 22 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 36 | 0.110 |
Why?
|
| Age Distribution | 1 | 2014 | 249 | 0.100 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 138 | 0.100 |
Why?
|
| DNA Replication Timing | 1 | 2012 | 3 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 336 | 0.100 |
Why?
|
| Rodentia | 1 | 2013 | 47 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 193 | 0.100 |
Why?
|
| Pregnancy | 2 | 2009 | 1737 | 0.100 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1992 | 22 | 0.100 |
Why?
|
| Fertilization in Vitro | 3 | 2002 | 57 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 850 | 0.090 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2002 | 33 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1992 | 84 | 0.090 |
Why?
|
| Glycoside Hydrolases | 1 | 2011 | 7 | 0.090 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2011 | 3 | 0.090 |
Why?
|
| Universities | 1 | 2014 | 539 | 0.090 |
Why?
|
| S Phase | 1 | 2011 | 37 | 0.080 |
Why?
|
| DNA Probes | 4 | 1996 | 33 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2011 | 420 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1617 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2000 | 209 | 0.080 |
Why?
|
| Mutation | 1 | 1994 | 1169 | 0.070 |
Why?
|
| Rats | 6 | 2011 | 3701 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2002 | 170 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 3 | 2002 | 254 | 0.070 |
Why?
|
| GC Rich Sequence | 1 | 2007 | 3 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 80 | 0.070 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 18 | 0.070 |
Why?
|
| Databases, Nucleic Acid | 1 | 2007 | 30 | 0.070 |
Why?
|
| Aphidicolin | 1 | 2007 | 3 | 0.070 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2007 | 6 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2803 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2022 | 358 | 0.070 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2007 | 29 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 48 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2007 | 92 | 0.070 |
Why?
|
| Poly A | 1 | 2007 | 33 | 0.070 |
Why?
|
| Aged | 3 | 2014 | 7982 | 0.060 |
Why?
|
| Extracellular Fluid | 1 | 2006 | 15 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2006 | 54 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2006 | 181 | 0.060 |
Why?
|
| Cryopreservation | 2 | 2004 | 33 | 0.060 |
Why?
|
| Adult | 4 | 2014 | 13458 | 0.060 |
Why?
|
| Internet | 1 | 2007 | 234 | 0.060 |
Why?
|
| Manganese | 1 | 2006 | 89 | 0.060 |
Why?
|
| Karyotyping | 2 | 2002 | 44 | 0.060 |
Why?
|
| Genomics | 1 | 2007 | 289 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2014 | 176 | 0.060 |
Why?
|
| Blastocyst | 2 | 2002 | 50 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 534 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 217 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 1984 | 16 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2003 | 27 | 0.050 |
Why?
|
| Fertility | 1 | 2004 | 63 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 4936 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2002 | 14 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 5950 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 59 | 0.050 |
Why?
|
| Reducing Agents | 1 | 2002 | 13 | 0.050 |
Why?
|
| Neoplasms | 1 | 1994 | 1341 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 102 | 0.050 |
Why?
|
| Sperm Head | 1 | 2002 | 10 | 0.050 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2002 | 14 | 0.050 |
Why?
|
| Microinjections | 2 | 1999 | 50 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2002 | 189 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2022 | 74 | 0.050 |
Why?
|
| Faculty | 1 | 2022 | 105 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 686 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2021 | 56 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 658 | 0.040 |
Why?
|
| Middle Aged | 2 | 2014 | 11819 | 0.040 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2000 | 3 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2000 | 33 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1989 | 198 | 0.040 |
Why?
|
| Stem Cells | 1 | 2001 | 151 | 0.040 |
Why?
|
| Nuclear Transfer Techniques | 1 | 1999 | 15 | 0.040 |
Why?
|
| Transfection | 1 | 2000 | 526 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 427 | 0.040 |
Why?
|
| Disulfides | 1 | 1999 | 92 | 0.040 |
Why?
|
| Prostatectomy | 1 | 1998 | 69 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2001 | 633 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 448 | 0.030 |
Why?
|
| Risk | 1 | 1997 | 289 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 134 | 0.030 |
Why?
|
| Ethanol | 1 | 1998 | 221 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 182 | 0.030 |
Why?
|
| Tropoelastin | 1 | 1995 | 13 | 0.030 |
Why?
|
| Decision Trees | 1 | 2014 | 22 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 144 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 9 | 0.030 |
Why?
|
| Organ Size | 1 | 1995 | 167 | 0.030 |
Why?
|
| Cisplatin | 2 | 1986 | 91 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2014 | 71 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1994 | 36 | 0.030 |
Why?
|
| Nucleosomes | 1 | 1994 | 31 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1990 | 68 | 0.030 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1993 | 5 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1995 | 278 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2014 | 89 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1996 | 560 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1994 | 181 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 599 | 0.020 |
Why?
|
| Cystoscopy | 1 | 1992 | 4 | 0.020 |
Why?
|
| Urine | 1 | 1992 | 12 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 503 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1989 | 19 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 1992 | 53 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1992 | 146 | 0.020 |
Why?
|
| Biopsy | 1 | 1992 | 176 | 0.020 |
Why?
|
| Base Sequence | 1 | 1993 | 997 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 479 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1986 | 132 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 366 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1990 | 18 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 45 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1990 | 8 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1990 | 6 | 0.020 |
Why?
|
| Sonication | 1 | 1989 | 14 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1989 | 158 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1989 | 140 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 1986 | 51 | 0.020 |
Why?
|
| Brain | 1 | 1995 | 1452 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1984 | 168 | 0.020 |
Why?
|
| Chromates | 1 | 1986 | 2 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 1986 | 4 | 0.020 |
Why?
|
| Succinimides | 1 | 1985 | 9 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1986 | 92 | 0.010 |
Why?
|
| Nucleoproteins | 1 | 1985 | 15 | 0.010 |
Why?
|
| Chromium | 1 | 1985 | 29 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1985 | 95 | 0.010 |
Why?
|
| Urea | 1 | 1985 | 44 | 0.010 |
Why?
|
| Antigens | 1 | 1984 | 58 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1984 | 77 | 0.010 |
Why?
|
| Haploidy | 1 | 2002 | 16 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 2002 | 14 | 0.010 |
Why?
|
| Protein Binding | 1 | 1984 | 1076 | 0.010 |
Why?
|
| Azure Stains | 1 | 1998 | 1 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 8 | 0.010 |
Why?
|
| Survival Rate | 1 | 1998 | 353 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1998 | 245 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1998 | 733 | 0.010 |
Why?
|
| Cell Survival | 1 | 1998 | 934 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 29 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 53 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1990 | 61 | 0.010 |
Why?
|
| Alleles | 1 | 1990 | 352 | 0.000 |
Why?
|
| Lamins | 1 | 1985 | 5 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 111 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1984 | 196 | 0.000 |
Why?
|
| Kinetics | 1 | 1986 | 698 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1984 | 301 | 0.000 |
Why?
|
| Cell Line | 1 | 1984 | 1416 | 0.000 |
Why?
|